A detailed history of Nebula Research & Development LLC transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 3,263 shares of LMAT stock, worth $298,466. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,263
Previous 3,923 16.82%
Holding current value
$298,466
Previous $323 Million 6.1%
% of portfolio
0.04%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$80.3 - $92.89 $52,998 - $61,307
-660 Reduced 16.82%
3,263 $303 Million
Q2 2024

Aug 14, 2024

SELL
$62.62 - $83.59 $177,903 - $237,479
-2,841 Reduced 42.0%
3,923 $323 Million
Q1 2024

May 15, 2024

BUY
$54.0 - $71.06 $26,568 - $34,961
492 Added 7.84%
6,764 $449 Million
Q4 2023

Feb 14, 2024

BUY
$45.37 - $58.41 $284,560 - $366,347
6,272 New
6,272 $356 Million

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.01B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.